Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis
Publication
, Journal Article
Zhu, S; Segura, T
Published in: Annals of biomedical engineering
2016
Duke Scholars
Published In
Annals of biomedical engineering
Publication Date
2016
Volume
44
Start / End Page
1983 / 1992
Publisher
Springer US
Related Subject Headings
- Vascular Endothelial Growth Factor Receptor-2
- Vascular Endothelial Growth Factor A
- Neovascularization, Physiologic
- Nanocapsules
- Immobilized Proteins
- Humans
- Human Umbilical Vein Endothelial Cells
- Delayed-Action Preparations
- Biomedical Engineering
- 4003 Biomedical engineering
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhu, S., & Segura, T. (2016). Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis. Annals of Biomedical Engineering, 44, 1983–1992.
Zhu, Suwei, and Tatiana Segura. “Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis.” Annals of Biomedical Engineering 44 (2016): 1983–92.
Zhu S, Segura T. Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis. Annals of biomedical engineering. 2016;44:1983–92.
Zhu, Suwei, and Tatiana Segura. “Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis.” Annals of Biomedical Engineering, vol. 44, Springer US, 2016, pp. 1983–92.
Zhu S, Segura T. Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis. Annals of biomedical engineering. Springer US; 2016;44:1983–1992.
Published In
Annals of biomedical engineering
Publication Date
2016
Volume
44
Start / End Page
1983 / 1992
Publisher
Springer US
Related Subject Headings
- Vascular Endothelial Growth Factor Receptor-2
- Vascular Endothelial Growth Factor A
- Neovascularization, Physiologic
- Nanocapsules
- Immobilized Proteins
- Humans
- Human Umbilical Vein Endothelial Cells
- Delayed-Action Preparations
- Biomedical Engineering
- 4003 Biomedical engineering